Targeting Metabolic Dependencies in Acute Myeloid Leukemia: A Dual Strategy using Arsenic Trioxide and Artesunate.
N. Balasundaram, A. Venkatraman, Y. Augustin, H. K. Palani, C. Regnault, A. Korula, U. P. Kulkarni, E. S. Edison, P. Balasubramanian, B. George, A. Abraham, S. Krishna, V. Mathews
This study investigates the combination of artesunate and arsenic trioxide to treat AML with reduced off-target effects on normal hematopoietic stem cells.
bioRxiv · Jun 23, 2024 · PreprintCancer Biology